Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Adjunctive Therapy in Bipolar Mania
NCT00216554Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of risperidone in bipolar I disorder, sponsored by Janssen Pharmaceutical. Primary endpoint: Young Mania Rating Scale at 6 months. Started Sep 2004; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00216554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216554.